BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17920108)

  • 1. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
    Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
    Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
    Movsas B; Moughan J; Sarna L; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Wasserman T; Bruner DW
    J Clin Oncol; 2009 Dec; 27(34):5816-22. PubMed ID: 19858383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline functioning scales of EORTC QLQ-C30 predict overall survival in patients with gastrointestinal cancer: a meta-analysis.
    Zang Y; Qiu Y; Sun Y; Fan Y
    Qual Life Res; 2024 Jan; ():. PubMed ID: 38227073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of chemotherapy on quality of life in advanced-stage lung cancer patients.
    Fernandes SS; Saini JK
    Indian J Cancer; 2023; 60(3):310-315. PubMed ID: 37787190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed Versus Immediate Start of Chemotherapy in Asymptomatic Patients With Advanced Cancer: A Meta-Analysis.
    Augustinus S; Thurairajah G; Besselink MG; van Laarhoven HWM; van Oijen MGH; Mackay TM; Wilmink JW
    Oncologist; 2023 Nov; 28(11):961-968. PubMed ID: 37589234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian Cancer Follow-up: A Preliminary Comparison of 2 Approaches.
    Lanceley A; Berzuini C; Burnell M; Gessler S; Morris S; Ryan A; Ledermann JA; Jacobs I
    Int J Gynecol Cancer; 2017 Jan; 27(1):59-68. PubMed ID: 28002208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors.
    Osann K; Wenzel L; McKinney C; Wagner L; Cella D; Fulci G; Scroggins MJ; Lankes HA; Wang V; Nephew KP; Maxwell GL; Mok SC; Conrads TP; Miller A; Birrer M
    Gynecol Oncol; 2023 Apr; 171():151-158. PubMed ID: 36905875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Outcomes with Curative and Palliative Therapies in Real World: Role of the Quality of Life Summary Score in Thoracic Oncology Patients.
    Tournoy KG; Adam V; Muylle I; De Rijck H; Everaert E; Eqlimi E; van Meerbeeck JP; Vercauter P
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisone.
    Lee CK; Gebski VJ; Coates AS; Veillard AS; Harvey V; Tattersall MH; Byrne MJ; Brigham B; Forbes J; Simes RJ;
    Springerplus; 2013; 2():391. PubMed ID: 24024086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of patient reported outcomes in advanced gastro-oesophageal cancer: a systematic review.
    Naher SK; Mercieca-Bebber R; Siu D; Grimison P; Stockler MR
    Intern Med J; 2023 Nov; 53(11):1946-1955. PubMed ID: 37605848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer.
    Reinisch M; Marschner N; Otto T; Korfel A; Stoffregen C; Wöckel A
    Breast Care (Basel); 2021 Oct; 16(5):491-499. PubMed ID: 34720809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective.
    Oza AM; Castonguay V; Tsoref D; Diaz-Padilla I; Karakasis K; Mackay H; Welch S; Weberpals J; Hoskins P; Plante M; Provencher D; Tonkin K; Covens A; Ghatage P; Gregoire J; Hirte H; Miller D; Rosen B; Maroun J; Buyse M; Coens C; Brady MF; Stuart GC
    Curr Oncol; 2011 Oct; 18 Suppl 2(Suppl 2):S20-7. PubMed ID: 21969808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexuality as a Prognostic Factor-Results of an Individual Patient Data NOGGO (North-Eastern German Society of Gynecological Oncology)-Meta-Analysis of 644 Recurrent Ovarian Cancer Patients Prior to Chemotherapy.
    Balint N; Woopen H; Richter R; Pirmorady-Sehouli A; Pietzner K; Sehouli J
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience and Expectations of Ovarian Cancer Patients in Australia.
    Holliday CM; Morte M; Byrne JM; Holliday AT
    J Oncol; 2018; 2018():7863520. PubMed ID: 29707001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC).
    Seifert H; Georgiou A; Alexander H; McLachlan J; Bodla S; Kaye S; Barton D; Nobbenhuis M; Gore M; Banerjee S
    Gynecol Oncol; 2015 Nov; 139(2):216-20. PubMed ID: 26318078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivorship Care for Women Living With Ovarian Cancer: Protocol for a Randomized Controlled Trial.
    Kvale E; Phillips F; Ghosh S; Lea J; Hoppenot C; Costales A; Sunde J; Badr H; Nwogu-Onyemkpa E; Saleem N; Ward R; Balasubramanian B
    JMIR Res Protoc; 2024 Feb; 13():e48069. PubMed ID: 38335019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and translational advances in ovarian cancer therapy.
    Konstantinopoulos PA; Matulonis UA
    Nat Cancer; 2023 Sep; 4(9):1239-1257. PubMed ID: 37653142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acupuncture as Part of Multimodal Analgesia for Chronic Pain.
    Robinson CL; Berger A; Sottosanti E; Li M; Kaneb A; Keefe J; Kim E; Kaye A; Viswanath O; Urits I
    Orthop Rev (Pavia); 2022; 14(3):38321. PubMed ID: 36168395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials.
    Hui D; Darke AK; Guthrie KA; Subbiah IM; Unger JM; Hershman DL; Krouse RS; Bakitas M; O'Rourke MA
    JCO Oncol Pract; 2022 Apr; 18(4):e442-e451. PubMed ID: 34606328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer.
    Hattori S; Yoshikawa N; Mogi K; Yoshida K; Yoshihara M; Tamauchi S; Ikeda Y; Yokoi A; Nishino K; Niimi K; Suzuki S; Kajiyama H
    Curr Oncol; 2021 Apr; 28(3):1663-1672. PubMed ID: 33946737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.